Evaxion Biotech A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q2 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q1 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2026 | 1 | $0.03 | $0.03 | $0.03 |
Evaxion Biotech A/S Earnings Date And Information
Evaxion Biotech A/S last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.12 by $0.08. The company had revenue of 3.03 M for the quarter and had revenue of 73,000 for the year. Evaxion Biotech A/S has generated $-8 earnings per share over the last year ($-8.11 diluted earnings per share) and currently has a price-to-earnings ratio of -0.77. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Evaxion Biotech A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | -$0.35 | $123,333 | $3.03 M | ||
| 06/28/2024 | Q2 2024 | -$1.14 | $52,000 | $153,887 | ||
| 08/14/2024 | Q1 2024 | -$0.07 | $0.26 | 0.33 | $50,881 | |
| 03/26/2024 | Q4 2023 | -$1.67 | $73,597 | |||
| 09/07/2023 | Q3 2023 | -$2.05 | $0 | |||
| 08/17/2023 | Q2 2023 | -$2.10 | $0 | |||
| 08/17/2023 | Q1 2023 | -$2.42 | $0 | |||
| 04/27/2023 | Q4 2022 | -$2.85 | $0 | |||
| 04/27/2023 | Q3 2022 | -$2.41 | $0 | |||
| 06/30/2022 | Q2 2022 | -$2.05 | $0 | |||
| 03/31/2022 | Q1 2022 | -$2.50 | $0 | |||
| 03/31/2022 | Q4 2021 | -$3.86 | $0 | |||
| 09/30/2021 | Q3 2021 | -$2.73 | $0 | |||
| 06/30/2021 | Q2 2021 | -$3.60 | $0 | |||
| 03/31/2021 | Q1 2021 | -$2.30 | $0 | |||
| 04/07/2021 | Q4 2020 | -$2.63 | $0 | |||
| 09/30/2020 | Q3 2020 | -$2.48 | $0 | |||
| 06/30/2020 | Q2 2020 | -$1.90 | $0 | |||
| 03/31/2020 | Q1 2020 | -$1.61 | $0 | |||
| 12/31/2019 | Q4 2019 | -$1.83 | $0 |
Evaxion Biotech A/S Earnings: Frequently Asked Questions
-
When is Evaxion Biotech A/S's earnings date?
Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
Did Evaxion Biotech A/S beat their earnings estimates last quarter?
In the previous quarter, Evaxion Biotech A/S (:EVAX) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.12 by $0.08.
-
How can I listen to Evaxion Biotech A/S's earnings conference call?
The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online.
-
How can I read Evaxion Biotech A/S's conference call transcript?
The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online.
-
How much revenue does Evaxion Biotech A/S generate each year?
Evaxion Biotech A/S (:EVAX) has a recorded annual revenue of $73,000.
-
How much profit does Evaxion Biotech A/S generate each year?
Evaxion Biotech A/S (:EVAX) has a recorded net income of $73,000. Evaxion Biotech A/S has generated $-8.11 earnings per share over the last four quarters.
-
What is Evaxion Biotech A/S's price-to-earnings ratio?
Evaxion Biotech A/S (:EVAX) has a price-to-earnings ratio of -0.77 and price/earnings-to-growth ratio is -0.02.
